Radosa M P, Owsianowski Z, Mothes A, Weisheit A, Vorwergk J, Asskaryar F A, Camara O, Bernardi T S, Runnebaum I B
Department of Gynaecology and Obstetrics, Jena University Hospital, Friedrich-Schiller-University Jena, Bachstraße 18, 07743 Jena, Germany.
Department of Gynaecology and Obstetrics, Jena University Hospital, Friedrich-Schiller-University Jena, Bachstraße 18, 07743 Jena, Germany.
Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:35-9. doi: 10.1016/j.ejogrb.2014.05.029. Epub 2014 Jun 2.
The use of laparoscopic myomectomy as a surgical treatment for uterine leiomyoma is associated with low intraoperative morbidity and short hospitalization. Limited data about the long-term outcome of this surgical approach are available. The aims of this study were to estimate the risk of uterine fibroid recurrence after laparoscopic myomectomy and to identify factors contributing to the rate of fibroid relapse.
Between 1996 and 2003, 331 patients underwent laparoscopic myomectomy to treat uterine leiomyoma in our hospital; 224 of these patients consented to participate in our 2009 follow-up survey. Clinical symptomatic uterine leiomyoma recurrence was defined as relapse. Recurrence rates at 24 and 60 months post-operatively were calculated for the study population. Fisher's exact tests were used to examine the impacts of factors previously linked to an increased risk of fibroid recurrence, including (1) patient age at the time of initial surgery, (2) pre-operative body mass index, (3) number and localization of uterine leiomyoma removed, and (4) pregnancy and (5) delivery after laparoscopic myomectomy on fibroid recurrence in our study cohort.
We observed 75 recurrences in 224 patients. The cumulative risk of recurrence was 4.9% at 24 months and 21.4% at 60 months post-operatively. An age of 30-40 years and the presence of more than one fibroid at the time of initial laparoscopic myomectomy were identified as factors significantly increasing the risk of symptomatic recurrence after laparoscopic myomectomy (31.25% and 38.71%, respectively; both p<0.01).
Patients with multiple uterine leiomyoma and those in the third decade of life should be counselled thoroughly about the risk of recurrence prior to laparoscopic myomectomy. The low observed recurrence rate in peri- and postmenopausal patients in our study may support the use of laparoscopic myomectomy as a uterus-preserving surgical alternative beyond the reproductive period.
腹腔镜子宫肌瘤切除术作为子宫平滑肌瘤的一种手术治疗方法,具有术中发病率低和住院时间短的特点。关于这种手术方法长期疗效的资料有限。本研究的目的是评估腹腔镜子宫肌瘤切除术后子宫肌瘤复发的风险,并确定导致肌瘤复发率的因素。
1996年至2003年期间,我院331例患者接受了腹腔镜子宫肌瘤切除术以治疗子宫平滑肌瘤;其中224例患者同意参加我们2009年的随访调查。临床有症状的子宫平滑肌瘤复发被定义为复发。计算了研究人群术后24个月和60个月的复发率。采用Fisher精确检验来研究先前与肌瘤复发风险增加相关的因素的影响,这些因素包括:(1)初次手术时患者的年龄,(2)术前体重指数,(3)切除的子宫平滑肌瘤的数量和位置,(4)妊娠以及(5)腹腔镜子宫肌瘤切除术后的分娩对我们研究队列中肌瘤复发的影响。
我们在224例患者中观察到75例复发。术后24个月的累积复发风险为4.9%,术后60个月为21.4%。初次腹腔镜子宫肌瘤切除术时年龄在30 - 40岁以及存在多个肌瘤被确定为腹腔镜子宫肌瘤切除术后有症状复发风险显著增加的因素(分别为31.25%和38.71%;两者p<0.01)。
对于患有多发性子宫平滑肌瘤的患者以及处于三十多岁的患者,在进行腹腔镜子宫肌瘤切除术之前,应充分告知其复发风险。我们研究中围绝经期和绝经后患者观察到的低复发率可能支持将腹腔镜子宫肌瘤切除术作为生育期之后保留子宫的手术选择。